CAG-hACE2-IRES-Luc-Tg
Nomenclature
C57BL/6JSmo-Tgtn(CAG-human ACE2-IRES-Luciferase-WPRE-polyA)Smoc
Cat. NO.
NM-TG-200002
Strain State
Repository Live
Model Description
Validation Data
Figure 1. Luciferase expression of the CAG-hACE2-IRES-Luciferase transgenic mice.
Figure 2. Western blot analysis of ACE2 protein from the CAG-hACE2-IRES-Luciferase transgenic mice.
Figure 3. Virus titers in the lungs of hACE2 Tg mice after SARS-CoV-2 infection. Groups of hACE2 Tg mice and wild type mice were inoculated with the same dose of SARS-CoV-2, the result shows that hACE2 Tg mice were highly susceptible to SARS-CoV-2 infection.
Figure 4. Body weight change in hACE2 Tg mice after drug treatment.
Figure 5. The viral load in the lung tissues of hACE2 Tg mice after drug treatment.
Publications 2piece
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
